In Chagas disease, circulating MMP-2 and -9 were proposed as biomarkers for asymptomatic to cardiac form progression [5–7], and alterations in their activity and expression during T. cruzi acute experimental infection have also been observed [8–11]. Here, MMP2 is linked to Chagas disease.